WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1989003830) 2-PYRIDINYLMETHYL (SULFINYL OR THIO)BENZIMIDAZOLES FOR TREATMENT OF DISEASES RELATED TO BONE LOSS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1989/003830    International Application No.:    PCT/SE1988/000575
Publication Date: 05.05.1989 International Filing Date: 27.10.1988
IPC:
C07D 401/12 (2006.01)
Applicants: AKTIEBOLAGET HÄSSLE [SE/SE]; S-431 83 Mölndal (SE) (For All Designated States Except US).
HÅKANSON, Rolf [SE/SE]; (SE) (For US Only).
LINDBERG, Per [SE/SE]; (SE) (For US Only).
WALLMARK, Björn [SE/SE]; (SE) (For US Only).
VÄÄNÄNEN, Kalervo [FI/FI]; (FI) (For US Only)
Inventors: HÅKANSON, Rolf; (SE).
LINDBERG, Per; (SE).
WALLMARK, Björn; (SE).
VÄÄNÄNEN, Kalervo; (FI)
Agent: MIKSCHE, Gerhard @; AB Astra, Patent and Trademark Department, S-151 85 Södertälje (SE)
Priority Data:
8704247-9 30.10.1987 SE
8704436-8 13.11.1987 SE
Title (EN) 2-PYRIDINYLMETHYL (SULFINYL OR THIO)BENZIMIDAZOLES FOR TREATMENT OF DISEASES RELATED TO BONE LOSS
(FR) 2-PYRIDINYLMETHYLE (SULFINYLE OU THIO)BENZIMIDAZOLES PERMETTANT LE TRAITEMENT DE MALADIES RELATIVES AUX PERTES OSSEUSES
Abstract: front page image
(EN)A method for the treatment of osteoporosis, Paget's disease of bone, hyperparathyroidism, malignant neoplasms causing hypercalcinemia, parodontal diseases and implant-related bone loss comprising administration to a patient suffering therefrom an amount of a compound of the formula (I), or a prodrug or a pharmaceutically acceptable salt thereof.
(FR)Procédé de traitement de l'ostéoporose, de la maladie osseuse de Paget, de l'hyperparathyroïdisme, de néoplasmes malins provoquant l'hypercalcémie, de maladies parodontales et de pertes osseuses relatives à des implants, consistant à administrer à un patient souffrant d'une des maladies précitées, une quantité d'un composé de formule (I), un promédicament, ou un sel pharmaceutiquement acceptable de celui-ci.
Designated States: AT, AU, BB, BG, BR, CH, DE, DK, FI, GB, HU, JP, KP, KR, LK, LU, MC, MG, MW, NL, NO, RO, SD, SE, SU, US.
European Patent Office (AT, BE, CH, DE, FR, GB, IT, LU, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)